Study: Abdominoplasty Patients Find Pain Relief with Xaracoll Implant
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
The FDA has cleared Merz Aesthetics’ Ultherapy PRIME to improve the appearance of skin laxity on the knees, expanding the device’s body indications.